1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CE2F7D82CD02AEE7652580C6001BF0FF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-scientific-publications-strategy-structure-staffing-budget?opendocument
18
19opendocument
203.80.4.76
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Scientific Publications

Best Practices in Scientific Publications Strategy: Structure, Staffing and Budget

ID: 5448


Features:

12 Info Graphics

18 Data Graphics

170+ Metrics

5 Narratives


Pages/Slides: 40


Published: 2017


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from Best Practices in Scientific Publications Strategy: Structure, Staffing and Budget”

STUDY OVERVIEW


Scientific publications are the principal way biopharmaceutical companies communicate critical clinical trial data to key external stakeholders such as physicians and payers. With increasing calls for greater transparency and data disclosure, global scientific publications leaders often find themselves in a balancing act - ensuring both scientific credibility and commercial viability.

Best Practices, LLC undertook benchmarking research to identify best practices that global scientific publications groups at pharmaceutical and biotechnology companies use to build scientific credibility and commercial success. In particular, this study provides benchmarks around the structure and leadership; staffing and budget levels; standard operating procedures and use of open source for global scientific publications function.

KEY TOPICS

  • Optimal Structure for the Global Publications Function
  • Impact of Open Platform on Publishing Strategy
  • Standard Operating Procedure for Scientific Publication
  • Key Internal Stakeholders Who Contribute to Publications Strategy
  • Publication Staffing and Budget

KEY METRICS

  • Leadership and Functional Oversight of Publication Function
  • Stakeholders Involved in the Development of Publication Strategy and Plan
  • Structure of Publication Strategy Function, Publication Planning Function and Publication Plan Delivery Function
  • Stakeholders Having Ultimate Responsibility for Publications Strategy, Publication Planning and Publication Plan Delivery
  • Impact of Open Platform on Publishing Strategy
  • Standard Operating Procedures (SOP) for Scientific Publication
  • Staff Time Allocated Towards SOP Training
  • Number of FTEs Working in Scientific Publications Function
  • Number of Internal and Outsourced FTEs Tasked to Specific Publication Activities
  • Budget Allocated to Scientific Publications Function
  • Publication Budget Sources
  • Factors Affecting Annual Publications Budget

SAMPLE KEY FINDINGS

  • Use of Open Access Publishing Platforms Increasing: Open access platforms are gaining popularity for publication processes; 44% of companies in the study believe such platforms will impact publication strategy going forward. Part of the allure for open access platforms is they make information readily available to physicians and patients alike. In the wake of open access platforms, companies foresee an impact on areas such as journal selection, publication approval and delivery, and speed of data disclosure.
  • Publication Group Budget Averages $6.5 Million: The average publication budget among study participants was $6.5 million while the median among participants was $1.6 million. A majority of publication budget is allocated to publication activities while 25% of budget goes to salaries.

METHODOLOGY


Best Practices, LLC engaged 20 leaders from 19 leading bio-pharmaceutical companies with direct experience working in scientific publishing. Almost 75% of participants are from the U.S. region.


Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Research; Distribution; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Alexion Pharmaceuticals; AstraZeneca; Bayer; Biotronik; Bioventus; Celgene; Genentech; Karyopharm Therapeutics; KimberlyClark; Lonza Inc.; McKessonHBOC; Nobel Biocare; Novartis; Portola Pharmaceuticals; Roche; Sanofi; Sirtex; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.